Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 134 record(s)

Req # A-2021-001401

Adverse Drug Reaction (ADR). Report number: E2B_04486423.

Organization: Health Canada

7 page(s)
February 2022

Req # A-2021-001402

Adverse Drug Reaction (ADR). Report number: E2B_04486433.

Organization: Health Canada

8 page(s)
February 2022

Req # A-2021-001404

Adverse Drug Reactions (ADRs) for LEFLUNOMIDE. Report numbers: E2B_03679360, E2B_03706180.

Organization: Health Canada

55 page(s)
February 2022

Req # A-2021-001408

Adverse Drug Reactions (ADRs) for LEFLUNOMIDE. Report numbers: E2B_03627801, E2B_03706804, E2B_04004981, E2B_03950968.

Organization: Health Canada

113 page(s)
February 2022

Req # A-2021-001413

Adverse Drug Reactions (ADRs) for HYDROXYCHLOROQUINE SULFATE. Report numbers: E2B_03523653, E2B_03676080.

Organization: Health Canada

36 page(s)
February 2022

Req # A-2021-001420

Adverse Drug Reaction (ADR) for HYDROXYCHLOROQUINE SULFATE. Report number: E2B_03690611.

Organization: Health Canada

18 page(s)
February 2022

Req # A-2021-001434

Adverse Drug Reaction (ADR) for HYDROXYCHLOROQUINE SULFATE. Report number: E2B_03833792.

Organization: Health Canada

37 page(s)
February 2022

Req # A-2021-001435

Adverse Drug Reaction (ADR) for LEFLUNOMIDE. Report number: E2B_03719493.

Organization: Health Canada

27 page(s)
February 2022

Req # A-2021-001437

Adverse Drug Reaction (ADR) for HYDROXYCHLOROQUINE SULFATE. Report number: E2B_03894461.

Organization: Health Canada

33 page(s)
February 2022

Req # A-2021-001444

Adverse Drug Reaction (ADR) for HYDROXYCHLOROQUINE SULFATE. Report number: E2B_03739988.

Organization: Health Canada

92 page(s)
February 2022
Date modified: